Rejuran Healer – Polynukleotid-Skinbooster 2 × 2 ml
Rejuran Healer – Polynukleotid-Skinbooster 2 × 2 ml

Rejuran Healer – Polynucleotide Skin Booster 2 × 2 ml

Rejuran Healer is an injectable skin booster based on highly pure polynucleotides (PN) to support skin quality as part of aesthetic treatment protocols.

– For the face, neck, and décolleté

– For use on structurally damaged, dry-looking, or mature skin

– Focuses on biostimulation rather than volume effect

– For injection by appropriately qualified medical professionals only

Medical device; use in accordance with the manufacturer's instructions for use (IFU). Package: 2 pre-filled syringes, 2 ml each.

100362
immediately available
€275.00

€68,750.00 1L

incl. tax, plus shipping Shipping excluded | Delivery time 2 - 3 days within Germany* | Abroad may vary

 

PN skinbooster for medical professionals

Rejuran Healer 2 × 2 ml Injectable polynucleotide gel for structure-focused aesthetic protocols

Rejuran Healer is a PN-based injectable product for professional applications in which skin quality and tissue structure are the main focus. Unlike conventional fillers, the product is not primarily intended to add volume. It must only be administered by appropriately qualified medical professionals in accordance with the current manufacturer’s instructions for use.

  • 2 prefilled syringes containing 2 ml each
  • Polynucleotides from highly purified DNA fragments
  • For the face, neck and décolletage in accordance with the IFU
  • For professional medical injection only
Rejuran Healer product packaging on a white background
Contents 2 prefilled syringes of 2 ml each
Product type Injectable PN-based medical device
Treatment focus Skin quality and tissue structure rather than conventional volume
Intended users Qualified medical professionals

Clear positioning within the treatment portfolio

Polynucleotides rather than a conventional filler concept

Rejuran Healer is intended for practices that offer PN-based injection protocols as a distinct category alongside hyaluronic acid fillers, PRP or device-based procedures. The emphasis is not on immediate volume, but on a structure-focused approach within professional aesthetic treatment concepts.

01 · PROTOCOL OBJECTIVE

Focus on skin quality

Developed for treatment concepts in which the condition and appearance of the skin are the primary considerations.

02 · PRODUCT PROFILE

Not a conventional volumising filler

Rejuran is not primarily used for contouring or for creating pronounced volume. This allows the product to be clearly differentiated during patient consultation.

03 · PRACTICE FORMAT

Two prefilled syringes

The 2 × 2 ml pack supports transparent planning and documentation within professional practice workflows.

Material and origin

What are polynucleotides?

Polynucleotides, abbreviated as PN, are long-chain DNA fragments. According to the manufacturer, the PN used in Rejuran are obtained from salmon DNA and processed using the company’s proprietary DOT™ technology. The result is an injectable PN gel for professional medical-aesthetic applications.

This material class differs conceptually from cross-linked hyaluronic acid fillers: the focus is not mechanical volume enhancement, but its integration into protocols intended to support skin structure and skin quality.

Application areas

For the face, neck and décolletage

The selection of treatment area, technique, injection depth, product quantity and treatment interval is a medical decision. It must be based on the individual baseline situation, the indication and the current manufacturer’s information.

FACE

Structure-focused facial protocols

For professional applications in the facial area in accordance with the approved intended purpose and current IFU.

NECK

Treatment of thinner skin areas

Suitability and technique must be assessed for each patient. Anatomical characteristics and risk zones must be taken into account.

DÉCOLLETAGE

Integration into coordinated treatment concepts

Application must only take place following professional assessment and within a documented treatment plan.

Safety and professional responsibility

Check before every application

  1. Verify the product version

    Check the packaging, batch number, expiry date, integrity and labelling of the supplied version.

  2. Determine the indication individually

    Consider the patient’s medical history, skin condition, contraindications, allergies and previous treatments.

  3. Follow the current IFU

    Injection technique, quantity, area and aftercare must be based on the manufacturer’s instructions and professional judgement.

  4. Document the application

    Record the batch, product quantity, treatment area, date, informed consent and any relevant reactions in a traceable manner.

Important: Rejuran Healer is intended exclusively for use by medical professionals who are appropriately qualified or authorised under national law. This product description does not replace the manufacturer’s IFU or appropriate medical training.

Product data

Pack contents and technical classification

Product name
Rejuran Healer
Pack contents
2 prefilled syringes of 2 ml each
Product category
Injectable PN-based medical device
Material principle
Polynucleotides from processed salmon DNA
Application areas
Face, neck and décolletage in accordance with the IFU
Volume effect
Not primarily intended for conventional volume enhancement
Intended users
Qualified medical professionals
Manufacturer
PharmaResearch Co., Ltd., Republic of Korea

Regulatory information

The European manufacturer and distribution information identifies REJURAN® as a Class III medical device bearing CE marking CE 2265. However, purchasing, supply and use must always be based on the labelling, conformity information and current IFU of the specific product version supplied.

Not for cosmetic use by unqualified users: The product must not be treated as a topical serum, microneedling product or freely usable ampoule.

Frequently asked questions from practices and purchasing teams

FAQ about Rejuran Healer

Is Rejuran Healer a dermal filler?

Rejuran Healer is an injectable PN product whose main focus is not conventional volume enhancement. It should therefore not be classified, either professionally or during patient consultation, in the same way as a conventional hyaluronic acid volumising filler.

What does PN stand for?

PN stands for polynucleotides. These are long-chain DNA fragments used in Rejuran as processed material for medical-aesthetic injection protocols.

Who may administer Rejuran Healer?

Only appropriately qualified medical professionals or professionals authorised under national law. The specific authorisation depends on the applicable national legislation and professional regulations.

Which areas is the product intended for?

The available product and manufacturer information identifies the face, neck and décolletage. The intended purpose stated in the current IFU of the supplied product version remains decisive.

Can Rejuran be combined with PRP, fillers or device-based procedures?

A combination must not be assumed to be generally suitable. The practitioner must determine the sequence, interval, product compatibility and patient suitability on the basis of the respective IFU and the individual clinical situation.

Is Rejuran Healer suitable for microneedling or topical application?

No. Rejuran Healer is an injectable medical device and not a cosmetic microneedling serum. It is not intended for freely selected topical or cosmetic use.

Where can contraindications and complete safety information be found?

Binding information is provided in the current manufacturer’s IFU for the supplied product version. It must be read in full before first use and remain available within the practice workflow.

For professional PN treatment concepts

A clearly defined product category for a clearly defined user group

Rejuran Healer combines a PN-based material concept with a practical pack format comprising two prefilled syringes of 2 ml each. Sale and use are restricted to qualified medical professionals; the current IFU and the labelling of the supplied batch always take precedence.

GPSR - General Product Safety Regulation

Responsible economic operator according to GPSR:

Obelis s.a.
Bad General Wahis, 53 B-1030 Brussels, Belgium
Tel: +32 2 732 59 54
[email protected]
https://www.obelis.net/contact/

Customers who bought this product also bought:

Product added to wishlist
Product added to compare.
group_work Cookie consent